Page last updated: 2024-09-04

ukrain and B16 Melanoma

ukrain has been researched along with B16 Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erdoğan, E; Genç, O; Savran, B; Yerlikaya, A1
Bezdeneznikh, N; Kudryavets, Y; Lykhova, O; Semesiuk, N; Skivka, L; Susak, Y; Trompak, O1

Other Studies

2 other study(ies) available for ukrain and B16 Melanoma

ArticleYear
Anticancer agent ukrain and bortezomib combination is synergistic in 4T1 breast cancer cells.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Berberine Alkaloids; Boronic Acids; Bortezomib; Breast Neoplasms; Cell Line, Tumor; Drug Synergism; Female; Humans; Melanoma, Experimental; Phenanthridines; Pyrazines

2014
The effect of monotherapy and combined therapy with NSC-631570 (ukrain) on growth of low- and high-metastasizing B16 melanoma in mice.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2011, Volume: 17, Issue:4

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Berberine Alkaloids; Cell Death; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Phenanthridines; Random Allocation; Tumor Cells, Cultured

2011